MedPath

SAITAMA MEDICAL UNIVERSITY

SAITAMA MEDICAL UNIVERSITY logo
🇯🇵Japan
Ownership
Private
Established
1972-01-01
Employees
501
Market Cap
-
Website
http://www.saitama-med.ac.jp

Clinical Trials

158

Active:0
Completed:103

Trial Phases

4 Phases

Phase 1:1
Phase 2:1
Phase 4:4
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (155 trials with phase data)• Click on a phase to view related trials

Not Applicable
149 (96.1%)
Phase 4
4 (2.6%)
Phase 1
1 (0.6%)
Phase 2
1 (0.6%)

Relationship Between Body Weight and Glycohemoglobin

Completed
Conditions
Type 2 Diabetes Mellitus
First Posted Date
2009-05-04
Last Posted Date
2009-05-04
Lead Sponsor
Saitama Medical University
Target Recruit Count
100
Registration Number
NCT00892372
Locations
🇯🇵

Department of Diabetes and Endocrinology, Saitama Medical Center, Saitama Medical University, Kawagoe, Saitama, Japan

Bucillamine Study of Holding Remission After Infliximab Dose-off

Phase 4
Conditions
Rheumatoid Arthritis
Interventions
First Posted Date
2008-07-16
Last Posted Date
2011-01-05
Lead Sponsor
Saitama Medical University
Target Recruit Count
40
Registration Number
NCT00716248
Locations
🇯🇵

Department of Rheumatology/Clinical Immunology, Saitama Medical Center, Saitama Medical University, Kawagoe, Saitama, Japan

Vertebral Fracture and Osteonecrosis Associated With High-dose Glucocorticoid

Completed
Conditions
Vertebral Fracture
Rheumatic Diseases
Osteonecrosis
First Posted Date
2008-05-19
Last Posted Date
2009-09-18
Lead Sponsor
Saitama Medical University
Target Recruit Count
60
Registration Number
NCT00679978

Effects of Angiotensin Receptor Antagonist on Prohibiting Cardiovascular Events on Hemodialysis Patients

Not Applicable
Completed
Conditions
Cardiovascular Disease
First Posted Date
2007-09-17
Last Posted Date
2007-09-17
Lead Sponsor
Saitama Medical University
Registration Number
NCT00530595

Effectiveness of Candesartan and Telmisartan on Morning Hypertension in Japanese Obese Patients

Not Applicable
Conditions
Hypertension
First Posted Date
2006-02-08
Last Posted Date
2007-01-11
Lead Sponsor
Saitama Medical University
Target Recruit Count
300
Registration Number
NCT00288717
Locations
🇯🇵

Saitama Medical School Department of Renal Medicine, Saitama City, Saitama, Japan

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.